EMA Withdrawn: Rienso (Ferumoxytol) — Takeda Pharma A/S

View source ↗

Summary

EMA has withdrawn Rienso (ferumoxytol) from the market in Europe.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Rienso (ferumoxytol)

Snippet

Status: Withdrawn. Therapeutic area: Anemia;Kidney Failure, Chronic. MAH: Takeda Pharma A/S. Decision date: 13/04/2015